International Journal of Cancer · 2008 · 40 citations · 33 references
MedicineGynecologyOncologyCancer EpidemiologyEpidemiologic MethodsWomen's HealthCervical CancerCervical CytologyCervical Intraepithelial NeoplasiaCervical LesionsCervical PathologyHuman Papillomavirus InfectionCervical Intraepithelial Neoplasia 2Cohort Study InvestigationHpv ClearanceHpv PersistenceHuman Papillomavirus EpidemiologyPap Smear CytologyPersistent Cervical InfectionPersistent Human Papillomavirus Infection
Human papillomavirus (HPV) persistence is essential for cervical cancer development. We accrued nested-cohort subjects from a population-based study to investigate the host and viral factors related to outcome of HPV infection. Women (age > or = 30 years old) with HPV-positive but normal cytology and negative colposcopy were invited to participate. After signing informed consent, every participant completed a structured questionnaire and had 6-monthly follow-ups of Pap smear, HPV testing and colposcopy. Total and type-specific HPV clearance rates as well as host and viral factors associated with clearance in 3-year longitudinal follow-up were analyzed. Adjusted hazard ratios (HRs) of progression to > or = cervical intraepithelial neoplasia (CIN) 2 according to baseline HPV of the women with normal cytology were calculated from national registry database. Among the 626 eligible women, 526 (median age 47, 29-75) were enrolled and 412 returned for follow-up at least once. The median follow-up of enrolled subjects was 23 months (range 6.8-39). The 3-year cumulative total HPV clearance rate was 49.0% (95% confidence interval [CI]: 43.3-54.7%). The median 3-year cumulative type-specific HPV clearance rate was 50.0% (range 0-100.0%) with a median time to clearance of 12.4 months (6.4-24.5). Older age was associated with significantly decreased total HPV clearance and decreased type-specific clearance in HPV-18 and -53, while high viral load was associated with decreased total and type-specific clearance. After adjusting confounding variables, the HR of developing > or =CIN2 in baseline HPV-positive women was 34.0-fold (95% CI: 15.5-74.7) as compared to HPV-negative women.
33
Ahmedin Jemal, Freddie Bray, Jacques Ferlay et al. · CA A Cancer Journal for Clinicians · 2011 · 55K citations · Full text
Global Cancer Statistics, 2002
Donald Maxwell Parkin, Freddie Bray, Jacques Ferlay et al. · CA A Cancer Journal for Clinicians · 2005 · 18.4K citations · Full text
Natural History of Cervicovaginal Papillomavirus Infection in Young Women
Robert Bierman, Leah Beardsley, Chee‐Jen Chang et al. · New England Journal of Medicine · 1998 · 2.3K citations · Full text
NATURAL HISTORY OF CERVICOVAGINAL PAPILLOMAVIRUS INFECTION IN YOUNG WOMEN
Guido Ruggero Loria, R Obert B Ierman, L Eah B Eardsley et al. · 1998 · 1.9K citations